Renal Physiology During Continuous Renal Replacement Therapy
AKI, Continuous Renal Replacement Therapy, Dialysis
About this trial
This is an interventional prevention trial for AKI
Eligibility Criteria
Inclusion Criteria:
AKI, according to KDIGO, stage 2 or 3 but with preserved urine production. Treated in the ICU at Sahlgrenska University Hospital Written, signed informed consent Male and female subjects ≥18 years
Exclusion Criteria:
Emergency need for dialysis Allergy to contrast media (used for CEUS)
Sites / Locations
- Sahlgrenska University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Starting at high blood pressure
Starting at low blood pressure
Patients in this arm are randomized to have high target blood pressure at MAP 80-90 mmHg during the first recordings, thereafter they will receive low blood pressure target 60-70 mm Hg
Patients in this arm are randomized to have low target blood pressure at MAP 60-70 mmHg during the first recordings, thereafter they will receive high blood pressure target 80-90 mm Hg